ReviewMini reviews in medicinal chemistry2026
A Comprehensive Review on Non-natural Amino Acid-based Modifications in Antibacterial Peptides.
Review in Mini reviews in medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Effect of Fatty Acid Chain Modification on the Self-Assembly Behavior and Antimicrobial Activity of Antimicrobial Peptides.Antibiotics (Basel, Switzerland) · 2026Article
- Aquatic-derived antimicrobial peptides and their strategically modified analogues as prospective anticancer therapeutics: a comprehensive systematic review of enhancement methodologies and mechanistic insights.Frontiers in chemistry · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Antimicrobial peptides are tiny molecular polypeptides that help living things fight off foreign microbes. According to recent studies, they come from a wide range of sources and can be found in a wide range of creatures, including microbes, plants, and animals. The method of action has the ability to act on intracellular targets in addition to the traditional membrane permeability mechanism. In terms of technology, antimicrobial peptides offer special benefits. They may successfully suppress a range of bacteria in the antibacterial area and are anticipated to address the issue of drug-resistant bacteria. Antiviral medications, such as those that block the herpes virus or influenza, are predicted to become a new generation of antiviral medications when they can precisely target cancer cells without harming healthy cells. This holds enormous promise for the field of biological medicine. However, it also faces problems such as production, safety, and activity retention, which limit its further development and large-scale application. The introduction of non-natural amino acids can address this issue because the natural antibacterial peptide is easily degraded by the protease. In addition, by introducing non-natural amino acids with special structures and properties, not only can the interaction between AMP and a target be optimized, but also the functional range of AMP can be expanded, and diversified innovation of functions is realized. This study primarily examined the use of non-natural amino acids in the creation of antimicrobial peptides. By exploiting the unique properties of these amino acids, we address current limitations of antimicrobial peptides and provide theoretical guidance for their further development and broad application.
Indexed as
Identifiers
41510715What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.